Leste Group acquires significant stake in Prestige Cosméticos
Leste Group has acquired a significant stake in Prestige Cosméticos, a leading Brazilian distributor of luxury fragrances and cosmetics with a growing presence in North America. Financial terms of the deal were not disclosed.
Founded in 2014 and led by Evelyse Britto and partners Shinji Motoyama and Roberto Thiry, Prestige has grown into a leading international distributor of fragrances and cosmetics. Prestige is the exclusive distributor in Brazil for many luxury perfume, fragrance and skin care brands, including Clinique, Dolce & Gabbana, Salvatore Ferragamo, Bulgari, Tom Ford, Acqua di Parma and Bond No. 9. The company also has significant operations outside of Brazil, and Leste will focus on working with management to accelerate its international expansion, particularly in North America.
"Our collaboration with Leste Group will allow us to expand Prestige's global distribution network, strengthen our retail footprint and e-commerce channels, enter into new brand partnerships and explore additional strategies to further enhance our business, " said Evelyse Britto, founder of Prestige Cosméticos. "Leste shares our vision for the future and we look forward to leveraging their financial expertise and industry knowledge to identify new opportunities and markets ahead. "
CEO and Founder Emmanuel Hermann said: "North America is the largest beauty market in the world, and our private equity investment in Prestige will help fuel its expansion in the region as the company prepares for its next phase of growth. This acquisition further demonstrates our extensive knowledge of the private equity markets and we look forward to leveraging this experience to continue to grow our private equity portfolio."
2026-09-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
EU Authorises Propionic Acid and Its Salts as Feed Additives Until 2035
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
UK Proposes Sharp Increase in MRL for Flubendiamide in Tea
-
Singapore Suspends Poultry Imports from Avian Flu-Affected Areas in Japan
-
EFSA Finds L-Cysteine Feed Additives Safe for All Animal Species
-
EFSA Confirms Safety of Triacylglycerol Lipase for Expanded Food Uses
-
EFSA Reports Avian Influenza Situation in Europe and Human Cases in Asia
Recommend Reading
-
EFSA Renews Authorisation of Inositol for Use in Fish and Crustacean Feed
-
EFSA Approves Cellulase from GM Aspergillus Niger with Low Allergy Risk
-
Canada Launches Re-Evaluation of Herbicide Iodosulfuron-Methyl-Sodium
-
Moldova Proposes Stricter Quality Standards for Edible Casein and Caseinates
-
“Clearing the Floor”: DKSH’s Privatization of Its Malaysian Subsidiary Signals a Silent Power Shift in Asia’s Supply Chain
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
Coke market remains stable with a strengthening trend, many regions in China initiate price increases
-
Consumption Fails to Match High Supply, October PP Refutes Peak Season Trend in China
-
Business Society’s Diesel Market Outlook on August 19, 2026: Volatile Rise
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 19, 2026: Rising